$173 Million is the total value of Noven Financial Group, Inc.'s 33 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 15.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | Sell | POWERSHARES QQQ TRUSTunit ser 1 | $23,164,000 | +5.7% | 148,717 | -1.3% | 13.36% | +1.5% |
| IWP | Sell | ISHARESrus md cp gr etf | $22,668,000 | +5.4% | 187,895 | -1.2% | 13.08% | +1.2% |
| IJS | Sell | ISHARESs&p 600 smcp val | $20,155,000 | +3.5% | 131,241 | -0.1% | 11.63% | -0.6% |
| IJT | Sell | ISHARESs&p 600 smcp grw | $19,665,000 | +3.3% | 115,576 | -0.1% | 11.34% | -0.8% |
| SCHD | Sell | SCHWAB Strategic TRus dividend eq | $5,733,000 | +7.1% | 112,046 | -2.0% | 3.31% | +2.9% |
| VUG | Sell | VANGAURD INDEX FUNDgrowth etf | $5,699,000 | +1.8% | 40,521 | -3.9% | 3.29% | -2.3% |
| PFF | Sell | ISHARESus pfd stk etf | $3,930,000 | -3.9% | 103,238 | -2.0% | 2.27% | -7.7% |
| VBK | Sell | VANGUARD INDEX FUNDsml cp grw etf | $3,782,000 | +1.3% | 23,516 | -3.9% | 2.18% | -2.7% |
| DVY | Sell | ISHARESselect dividend etf | $2,919,000 | -9.1% | 29,617 | -13.6% | 1.68% | -12.7% |
| IWF | Sell | ISHARESrus 1000 grw etf | $2,135,000 | -1.8% | 15,849 | -8.8% | 1.23% | -5.7% |
| IVW | Sell | ISHARESs&p 500 growth | $2,079,000 | -2.7% | 13,607 | -8.6% | 1.20% | -6.5% |
| VTI | Sell | VANGAURD INDEX FUNDtotal stk mkt | $1,593,000 | -11.5% | 11,608 | -16.4% | 0.92% | -15.0% |
| AMPE | Sell | AMPIO PHARMACEUTICALS INC | $643,000 | +328.7% | 158,059 | -35.7% | 0.37% | +312.2% |
| WPC | Sell | W P CAREY INC | $607,000 | -4.3% | 8,815 | -6.3% | 0.35% | -8.1% |
| SLV | Sell | ISHARES SILVER TRUSTishares | $569,000 | +0.9% | 35,605 | -0.6% | 0.33% | -3.2% |
| IMMU | Sell | IMMUNOMEDICS INC | $194,000 | -1.0% | 12,000 | -14.3% | 0.11% | -5.1% |
| BND | Exit | VANGUARD BD INDEX FD INCtotal bond mrkt | $0 | – | -2,765 | -100.0% | -0.14% | – |
| VXUS | Exit | VANGUARD STAR FDvg tl intl stk f | $0 | – | -4,346 | -100.0% | -0.14% | – |
| VOE | Exit | VANGUARD INDEX FDS QMT &mcap vl idxvip | $0 | – | -17,438 | -100.0% | -1.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 26 | Q1 2020 | 3.3% |
| VANGUARD INDEX FDS | 26 | Q1 2020 | 1.5% |
| FACEBOOK INC | 26 | Q1 2020 | 0.8% |
| W P CAREY INC | 26 | Q1 2020 | 0.5% |
| ISHARES GOLD TRUST | 25 | Q1 2020 | 3.0% |
| AMPIO PHARMACEUTICALS INC | 25 | Q1 2020 | 18.3% |
| BERKSHIRE HATHAWAY INC DEL | 24 | Q1 2020 | 3.0% |
| APPLE INC | 24 | Q1 2020 | 1.3% |
| SCHWAB STRATEGIC TR | 22 | Q1 2020 | 3.8% |
| ISHARES SILVER TRUST | 22 | Q1 2019 | 1.0% |
View Noven Financial Group, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-05-01 |
| 13F-HR | 2020-02-10 |
| 13F-HR | 2019-11-13 |
| 13F-HR | 2019-08-12 |
| 13F-HR | 2019-05-10 |
| 13F-HR | 2019-02-06 |
| 13F-HR | 2018-11-13 |
| 13F-HR | 2018-08-10 |
| 13F-HR | 2018-05-09 |
| 13F-HR | 2018-02-14 |
View Noven Financial Group, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.